Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. (Q45950196)
Jump to navigation
Jump to search
scientific article published on 20 April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. |
scientific article published on 20 April 2009 |
Statements
1 reference
2 references
Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. (English)
1 reference
George Blumenschein
1 reference
Daniel D Karp
1 reference
Luis G Paz-Ares
1 reference
Silvia Novello
1 reference
Paul Haluska
1 reference
Linda Garland
1 reference
Felipe Cardenal
1 reference
L Johnetta Blakely
1 reference
Peter D Eisenberg
1 reference
Corey J Langer
1 reference
Faye M Johnson
1 reference
Stephanie Green
1 reference
Antonio Gualberto
1 reference
20 April 2009
1 reference
27
1 reference
15
1 reference
2516-2522
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference